Maxim Group Downgrades Palisade Bio to Hold

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

Maxim Group analyst Naz Rahman downgrades Palisade Bio (NASDAQ:PALI) from Buy to Hold.

Total
0
Shares
Related Posts
Read More

Worried About A Housing Shortage? These 2 Equity REITs Paying Large Dividends Could Benefit Investors

The five-year average dividend yield for various real estate investment trusts is amongst the lowest for manufactured homes at 2.6%, SP Global reported. Manufactured homes cost only two-thirds the rate of existing site-built homes and less than half the cost of new site-built homes, per Deloitte.

ELS